NKTRNektar Therapeutics

$73.85

Who owns NKTR

215 institutions reported holding NKTR for 2026Q1, together 108% of the company, more than the 179 a quarter earlier.

215

Institutions reporting a position · as of 2026Q1 · up from 179 the quarter before

Shares held by institutions
26.7M

Shares held by institutions · 108% of the company · long US equity positions only, as reported on Form 13F

Reported value
$1.92B

Reported value · at 2026-03-31 prices, not today's

Top 5 holders
45%

Top 5 holders · of the whole company, between five filers

Details
Reporting quarter2026-03-31
2026Q1
Quarters on record
52
New positions
64
Positions exited
35
Added to
74
Reduced
46
Top 10 holdersof the company
58%
Institutional ownership by quarter, 2013Q2 to 2026Q1
QuarterFilersSharesReported value
2026Q121526.7M$1.92B
2025Q417917.3M$732M
2025Q315414.4M$820M
2025Q21097.7M$198M
2025Q1157123.8M$84M
2024Q4146132.9M$124M
2024Q3139140.7M$183M
2024Q2134135.4M$168M
2024Q1122113.0M$105M
2023Q4126119.2M$67M
2023Q3137143.2M$85M
2023Q2146137.8M$79M
2023Q1193172.7M$121M
2022Q4212168.8M$381M
2022Q3228175.2M$561M
2022Q2223182.4M$693M
Largest reported holders, 2026Q1
HolderShares% of companyValue
FMR LLC4.3M17%$310M
BVF INC/IL2.6M10%$184M
Two Seas Capital LP2.0M7.9%$141M
VANGUARD GROUP INC1.5M6.0%$106M
TWO SIGMA INVESTMENTS, LP0.9M3.8%$67M
Prosight Management, LP0.7M3.0%$53M
BlackRock Inc.0.7M2.8%$50M
MORGAN STANLEY0.7M2.7%$47M
ARMISTICE CAPITAL, LLC0.6M2.3%$42M
Invesco Ltd.0.6M2.3%$41M

SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.

reading the register…